Tracking Medicare news, policy, and coverage changes.
(MedPage Today) -- Senate Democrats failed Thursday to kill an artificial intelligence (AI)-driven prior authorization demonstration program for traditional Medicare, but they say this isn't the end of the road. "Democrats tried to stop AI prior...
Read full article →(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
Read full article →(MedPage Today) -- Higher cumulative physiologic stress reflected in salivary cortisol was associated with faster cognitive decline, a prospective study showed. Older adults with high cumulative cortisol exposure had worse composite global cognition...
Read full article →(MedPage Today) -- The Medicare physician fee schedule proposed by CMS for 2027 will result in a 1.5% payment cut for hematology/oncology and a 1.5% increase for radiation oncology, the American Society of Clinical Oncology estimated. The FDA...
Read full article →(MedPage Today) -- MONTREAL -- Diabetic retinopathy severity and the risk of vision-threatening complications decreased significantly in patients treated with the investigational VEGF inhibitor tarcocimab, a randomized, sham-controlled study...
Read full article →Industry giant UnitedHealthcare is adding its voice to the chorus of insurers criticizing the current state of the No Surprises Act's independent dispute resolution process.
Read full article →Stay up to date on the latest in health tech, digital health and health AI news with this weekly brief.
Read full article →The Trump administration said Monday Americans in Congo, where Ebola is spreading, must spend three weeks in a third country before coming home.
Read full article →California-based vegetable producer Taylor Farms said Friday that it will remove products potentially linked to a growing cyclosporiasis outbreak across the country. “Based on information provided yesterday by the FDA [Food and Drug Administration], Taylor Farms de Mexico is voluntarily removing all iceberg lettuce sourced from central Mexico,” the company said in its statement. “While...
Read full article →GSK said the mixed Phase 3 results for camlipixant mean this pill “is unlikely to transform patient care” in recurrent chronic cough. GSK is stopping work in this indication, a setback to a program once hoped to yield a new blockbuster product for the company’s respiratory drug portfolio. The post GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough appeared first on MedCity News .
Read full article →The opportunity ahead is to treat physician well-being as a core strategic priority, measured with the same rigor and acted upon with the same urgency as any other critical performance domain. The post Why Specialty-Specific Measurement and Intervention Are Essential to Address Healthcare Burnout appeared first on MedCity News .
Read full article →Physicians who offer counseling on quitting cigarettes and alcohol during patient visits would get a 19% increase in reimbursement under a proposed Medicare change.
Read full article →